Department of Medical Oncology, University Hospital of Liège, CHU Sart Tilman, Liège, Belgium.
Laboratory of Human Genetics, GIGA Research Center, Liège, Belgium.
Cancer Rep (Hoboken). 2022 Oct;5(10):e1571. doi: 10.1002/cnr2.1571. Epub 2021 Oct 12.
The spread of the COVID-19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients.
An analysis of cancer patients fears, and awareness of COVID-19 has been done in this study.
We analyzed cancer patients' reactions to the pandemic and their perception of oncological care reorganization, through a 12-item survey, proposed at the peak of pandemic and 3 months later. Overall, 237 patients were included in the study. During the peak of pandemic 34.6% of patients were more worried about COVID-19 than cancer versus 26.4% in the post-acute phase (p = .013). Although 49.8% of patients in the acute phase and 42.3% in the post-acute phase considered their risk of death if infected ≥50%, and more than 70% of patients thought to be at higher risk of complications, the majority of them did not consider the possibility to stop or delay their treatment. Patients were more interested in following news about COVID-19 than cancer and they complied with all preventive measures in more than 90% of the cases.
Although cancer patients worried about COVID-19 and evaluated the risk of complication or death due to COVID-19 as extremely high, they were still asking for the best oncological treatment.
COVID-19 大流行的传播导致所有人和医院的活动迅速重组，对癌症患者产生了影响。
本研究分析了癌症患者对 COVID-19 的恐惧和认识。
我们通过在大流行高峰期和 3 个月后提出的 12 项调查，分析了癌症患者对大流行的反应及其对肿瘤治疗重组的看法。共有 237 名患者纳入本研究。在大流行高峰期，34.6%的患者比癌症更担心 COVID-19，而在急性后期为 26.4%（p=0.013）。尽管 49.8%的急性患者和 42.3%的急性后期患者认为如果感染，其死亡风险≥50%，并且超过 70%的患者认为自己更有可能发生并发症，但大多数患者并不认为有可能停止或延迟他们的治疗。与癌症相比，患者对新冠病毒的新闻更感兴趣，并且在超过 90%的情况下都遵守了所有预防措施。
尽管癌症患者担心 COVID-19，并将因 COVID-19 而导致并发症或死亡的风险评估为极高，但他们仍在寻求最佳的肿瘤治疗。
